Antithrombin Supplementation May Not Decrease Heparin Requirements nor Diminish the Prevalence of Bleeding and/or Thrombosis in Adult Patients on Venovenous Extracorporeal Membrane Oxygenation: Enough Evidence for a Definitive Banning Order?
- PMID: 33731638
- DOI: 10.1097/CCM.0000000000004838
Antithrombin Supplementation May Not Decrease Heparin Requirements nor Diminish the Prevalence of Bleeding and/or Thrombosis in Adult Patients on Venovenous Extracorporeal Membrane Oxygenation: Enough Evidence for a Definitive Banning Order?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.Crit Care Med. 2020 Nov;48(11):1636-1644. doi: 10.1097/CCM.0000000000004590. Crit Care Med. 2020. PMID: 32947474 Clinical Trial.
References
-
- Panigada M, Cucino A, Spinelli E, et al. A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation. Crit Care Med. 2020; 48:1636–1644
-
- du Cheyron D, Bouchet B, Bruel C, et al. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: A case-control study. Crit Care. 2006; 10:R45
-
- Ryerson L, Lequier L. Anticoagulation in pediatric extracorporeal life support—time for a more direct approach? Pediatr Crit Care Med. 2020; 21–9:841–843
-
- Lafargue M, Joannes-Boyau O, Honoré PM, et al. Acquired deficit of antithrombin and role of supplementation in septic patients during continuous veno-venous hemofiltration. ASAIO J. 2008; 54:124–128
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical